Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists
摘要:
Structural simplification of the core moieties of obeline and ergoline somatostatin sst(1) receptor antagonists, followed by systematic optimization, led to the identification of novel, highly potent and selective sst(1) receptor antagonists. These achiral, non-peptidic compounds are easily prepared and show promising PK properties in rodents. (C) 2009 Elsevier Ltd. All rights reserved.
Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists
摘要:
Structural simplification of the core moieties of obeline and ergoline somatostatin sst(1) receptor antagonists, followed by systematic optimization, led to the identification of novel, highly potent and selective sst(1) receptor antagonists. These achiral, non-peptidic compounds are easily prepared and show promising PK properties in rodents. (C) 2009 Elsevier Ltd. All rights reserved.
Piperazine derivatives having sst1 antagonistic activity
申请人:Troxler J. Thomas
公开号:US20060079527A1
公开(公告)日:2006-04-13
The invention provides compounds of formula (I), wherein X, R
1
and R
2
are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals.
PIPERAZINE DERIVATIVES HAVING SST1 ANTAGONISTIC ACTIVITY
申请人:Novartis AG
公开号:EP1446399B1
公开(公告)日:2005-05-04
US7271168B2
申请人:——
公开号:US7271168B2
公开(公告)日:2007-09-18
[EN] PIPERAZINE DERIVATIVES HAVING SST1 ANTAGONISTIC ACTIVITY<br/>[FR] DERIVES DE PIPERAZINE AYANT UNE ACTIVITE ANTAGONISTE SST1
申请人:NOVARTIS AG
公开号:WO2003040125A1
公开(公告)日:2003-05-15
The invention provides compounds of formula (I), wherein X, R1 and R2 are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals.
Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists
Structural simplification of the core moieties of obeline and ergoline somatostatin sst(1) receptor antagonists, followed by systematic optimization, led to the identification of novel, highly potent and selective sst(1) receptor antagonists. These achiral, non-peptidic compounds are easily prepared and show promising PK properties in rodents. (C) 2009 Elsevier Ltd. All rights reserved.